THE ROLE OF BUSINESS INTELLIGENCE (BI) IN SERVICE INNOVATION: AN AMBIDEXTERITY PERSPECTIVE

Rozan O. Maghrabi, Richelle L. Oakley, Ravi Thambusamy, Lakshmi Iyer

Americas Conference on Information Systems · 2011 · 13 citations · 34 references

DOIFull text

Open access

Concepts

Abstract

Drug resistance is a major obstacle to the success of EGFR-targeted therapy. We recently studied the mechanism by which a small subset of EGFR mutant lung cancer cells remains viable after EGFR inhibition. We found that this drug-tolerant subpopulation develops because EGFR inhibition prevents AKT activity and thus inactivates Ets-1 function. In this article, we discuss how changes in intrinsic cell signaling after EGFR inhibition open a new avenue to drug resistance in NSCLCs, and comment on combined TKI and MEK inhibitor treatment to reduce the probability of emergent resistance to EGFR TKIs.

References

34